Physician profile
Anna C Davis
NPI 1336212729
$292.91
in general payments reported to CMS, 2019-2025
10 companies · $53.82 in 2025
The $53.82 reported for 2025 was less than what a typical Addiction Medicine (Internal Medicine) provider received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.48 · 2020: $30.63 · 2022: $14.55 · 2023: $60.19 · 2024: $52.24 · 2025: $53.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $82.12 | 2019-2025 | Sublocade |
| Vyera Pharmaceuticals, LLC | $51.47 | 2019-2020 | |
| Horizon Therapeutics Plc | $48.42 | 2023 | Krystexxa |
| Acella Pharmaceuticals, LLC | $20.84 | 2024 | NP Thyroid 60 |
| Qol Medical, LLC | $17.51 | 2019 | |
| Exact Sciences Corporation | $16.91 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $16.32 | 2024 | Krystexxa |
| Surmodics, INC. | $14.55 | 2022 | |
| Alkermes, INC. | $13.00 | 2019 | |
| Athena Bioscience, LLC | $11.77 | 2023 | Nexiclon Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.